课题基金 / 基金详情

Development of a plant-grown subunit vaccine against respiratory syncytial virus

Development of a plant-grown subunit vaccine against respiratory syncytial virus
开发抗呼吸道合胞病毒的植物亚单位疫苗
批准号:
7802544
负责人:
Dennis Edward Buetow
金额:
$29.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-15 至 2012-02-29

项目摘要

项目成果

Dennis Edward Buetow的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):呼吸道合胞病毒(RSV)引起的疾病是全球重大的卫生保健负担。呼吸道合胞病毒感染全世界几乎所有的儿童,包括发达国家和发展中国家。再感染很常见,因为自然感染不能产生持久的免疫。此外,严重的呼吸道合胞病毒感染越来越多地发生在老年人中。尽管大规模努力生产对抗RSV的有效疫苗,但目前还没有疫苗可用。
英文摘要
DESCRIPTION (provided by applicant): Respiratory syncytial virus (RSV)-caused disease represents a significant health care burden worldwide. The RSV infects virtually all children throughout the world in both developed and developing countries. Re-infection is common because natural infection does not induce lasting immunity. Also, severe RSV infections are increasingly occurring among the elderly. In spite of wide-scale efforts to produce an effective vaccine against RSV, no vaccine is yet available. Development of an inexpensive edible plant-based oral vaccine is an innovative approach for the control of RSV. The present study extends the strategy of using a plant-based oral vaccine to a respiratory pathogen for the first time. Even if lasting immunity is not obtained with the plant-based vaccine, it would be relatively low in cost to use such a vaccine during successive RSV seasons. We have shown previously that oral immunization of mice with transgenic tomato fruit expressing an RSV- subunit protein, i.e., the F-protein, induces a systemic immune response. This "proof of principle" Phase I study will optimize the expression of the RSV-F protein in the transgenic tomato fruit and determine the capacity of this orally-given antigenic protein to protect against an RSV challenge in two commonly-used models for RSV studies, the Balb/c mouse and the cotton rat. Success will validate the further development of our tomato- based vaccine against RSV and set the stage for a Phase II study. Such a vaccine will definitely make a difference and have an enduring impact on human health. PUBLIC HEALTH RELEVANCE: Respiratory syncytial virus-caused disease is a significant health care burden worldwide, but no vaccine is available. We are developing an inexpensive vaccine using tomato plants to control this virus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a plant-grown subunit vaccine against respiratory syncytial virus
  • 批准号:
    8044041
  • 项目类别:
  • 资助金额:
    $29.07万
  • 财政年份:
    2010
  • 负责人:
    Dennis Edward Buetow
  • 依托单位:
海外基金